logologo
QuantliQuantli

Galectin Therapeutics Inc

GALT

NASDAQ

Biotechnology

$3.44

USD

-0.09 (-2.55%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $356.00M

Volume 388.2K

Price Target

$11.00$11.00

USD

The 1 analysts offering 1-year price forecasts have a max estimate of $11.00 and a min estimate of $11.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$11.00

Implied Upside

+219.8%

Analyst Covering

1

Consensus

Buy

Signal Quality

Consensus Freshness

100%

Most ratings are recent - from the last 3 months

Analyst Agreement

High

Targets are closely clustered - analysts largely agree

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

1 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

1 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Matthew Keller

HC Wainwright & Co.

Buy

Reiterated

1 month ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

AGEN

Agenus Inc

$7.32

+4.6%

STRO

Sutro Biopharma Inc

$20.48

-3.9%

ZNTL

Zentalis Pharmaceuticals Inc

$3.56

-14.2%

SC

SCTX

Scribe Therapeutics Inc

$20.73

+1.8%

LYEL

Lyell Immunopharma Inc

$13.95

+1.5%

IKT

Inhibikase Therapeutics Inc

$2.41

0.0%

DMAC

DiaMedica Therapeutics Inc

$6.68

-1.0%

ABEO

Abeona Therapeutics Inc

$5.99

-5.7%

SABS

SAB Biotherapeutics Inc

$3.70

-1.3%

IPSC

Century Therapeutics Inc

$1.92

-0.5%